Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 9-Feb-2010
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 14)
Release
Date [down]		 Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
5-Feb-10Ford Investor Services, Inc.N/AIndustry Value Graph: FOLD , BHRT , BNVI , HALO , OPTR , OREX , RNN , VNDA -- DRUGS3$4  View Abstract
5-Feb-10Ford Investor Services, Inc.N/AValue Graph: VANDA PHARMACEUT -- VNDA1$4  View Abstract
3-Feb-10Wright ReportsN/AWright Investors Service Comprehensive Report for Vanda Pharmaceuticals Inc.40$65  View Abstract
2-Feb-10EconomicInvestorN/A"The Economy Matters" Report for VNDA: the economy's impact on VNDA's price and risk, featuring the powerful EconomicInvestor Star Rating6$15  View Abstract
28-Jan-10Zacks Investment Research Inc.N/AVANDA PHARMACT (VNDA) Zacks Company Snapshot1$10  View Abstract
13-Jan-10Zacks Investment Research Inc.N/AVANDA PHARMACT (VNDA) Zacks Company Snapshot1$10  View Abstract
29-Dec-09Zacks Investment Research Inc.N/AVANDA PHARMACT (VNDA) Zacks Company Snapshot1$10  View Abstract
30-Mar-09ValuEngine, Inc.N/AValuEngine Industry Report for DRUGS18$49  View Abstract
30-Mar-09ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for VNDA13$25  View Abstract
29-Mar-09PriceTarget Research, Inc.N/ABiotechnology Intelligence Monitor: overall outlook STRONG - 25 new Leaders; 12 new Laggards.52$20  View Abstract
Next 4
Independent Reports (Showing 1 to 10 of 14)
Release
Date [down]		 Contributor Author Title Pages Price More Info
5-Feb-10Ford Investor Services, Inc.N/AIndustry Value Graph: FOLD , BHRT , BNVI , HALO , OPTR , OREX , RNN , VNDA -- DRUGS3$4View Abstract
5-Feb-10Ford Investor Services, Inc.N/AValue Graph: VANDA PHARMACEUT -- VNDA1$4View Abstract
3-Feb-10Wright ReportsN/AWright Investors Service Comprehensive Report for Vanda Pharmaceuticals Inc.40$65View Abstract
2-Feb-10EconomicInvestorN/A"The Economy Matters" Report for VNDA: the economy's impact on VNDA's price and risk, featuring the powerful EconomicInvestor Star Rating6$15View Abstract
28-Jan-10Zacks Investment Research Inc.N/AVANDA PHARMACT (VNDA) Zacks Company Snapshot1$10View Abstract
13-Jan-10Zacks Investment Research Inc.N/AVANDA PHARMACT (VNDA) Zacks Company Snapshot1$10View Abstract
29-Dec-09Zacks Investment Research Inc.N/AVANDA PHARMACT (VNDA) Zacks Company Snapshot1$10View Abstract
30-Mar-09ValuEngine, Inc.N/AValuEngine Industry Report for DRUGS18$49View Abstract
30-Mar-09ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for VNDA13$25View Abstract
29-Mar-09PriceTarget Research, Inc.N/ABiotechnology Intelligence Monitor: overall outlook STRONG - 25 new Leaders; 12 new Laggards.52$20View Abstract
Next 4

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.